XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.631
-0.000 (-0.03%)
At close: Dec 5, 2025, 4:00 PM EST
0.620
-0.011 (-1.73%)
After-hours: Dec 5, 2025, 5:47 PM EST
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$647,769
Market Cap
4.21M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Jan 1, 2022 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XRTX News
- 6 weeks ago - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering - GlobeNewsWire
- 6 weeks ago - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency - GlobeNewsWire
- 6 weeks ago - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 7 weeks ago - XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - GlobeNewsWire
- 3 months ago - XORTX Initiates IND Preparation for XORLO™ in Gout Program - GlobeNewsWire
- 4 months ago - XORTX Completes USD $114,500 Private Placement - GlobeNewsWire
- 4 months ago - XORTX Completes Non-Brokered Private Placement of Units - GlobeNewsWire
- 5 months ago - XORTX Announces USD $925,000 Private Placement - GlobeNewsWire